
Sign up to save your podcasts
Or


Bloomberg Intelligence Medtech Analyst Matthew Henriksson discusses development of plant based formula alternative and the potential ability to disrupt this market with Kate Farms CEO Brett Matthews.
By Bloomberg4.6
1414 ratings
Bloomberg Intelligence Medtech Analyst Matthew Henriksson discusses development of plant based formula alternative and the potential ability to disrupt this market with Kate Farms CEO Brett Matthews.

1,298 Listeners

538 Listeners

409 Listeners

2,168 Listeners

427 Listeners

1,107 Listeners

2,344 Listeners

970 Listeners

342 Listeners

195 Listeners

67 Listeners

30 Listeners

554 Listeners

512 Listeners

354 Listeners

4 Listeners

58 Listeners

233 Listeners

231 Listeners

69 Listeners

148 Listeners

81 Listeners

85 Listeners

402 Listeners

21 Listeners

13 Listeners

7 Listeners

2 Listeners

120 Listeners